Diagnosis and risk stratification of PI-RADS v2.1 category 3–5 lesions using amide proton transfer imaging - Summary - MDSpire

Diagnosis and risk stratification of PI-RADS v2.1 category 3–5 lesions using amide proton transfer imaging

  • By

  • Hongkun Fang

  • Weishu Hou

  • Qun Wang

  • Xiaoyu Zhang

  • Xiao Wang

  • Shuhai Zhang

  • Shoubin Li

  • Xiaohu Li

  • Yongqiang Yu

  • May 6, 2025

  • 0 min

Share

Objective:

Consider adding context about the significance of APTWI in current diagnostic practices.

Key Findings:
  • Summarize insights into fewer, more impactful points.
Interpretation:

Emphasize potential clinical implications of findings.

Limitations:
  • Suggest how future studies might address identified limitations.
Conclusion:

Reiterate the need for further research more emphatically.

Original Source(s)

Diagnosis and risk stratification of PI-RADS v2.1 category 3–5 lesions using amide proton transfer imaging

  • by Hongkun Fang, Weishu Hou, Qun Wang, Xiaoyu Zhang, Xiao Wang, Shuhai Zhang, Shoubin Li, Xiaohu Li, Yongqiang Yu

  • May 6, 2025

Related Content

Local staging with multiparametric MRI in daily clinical practice: diagnostic accuracy and evaluation of a radiologic learning curve

Impact of the PI-QUAL MRI quality score on histopathological up-staging from MRI fusion biopsy to final prostatectomy specimen

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study